However, in contrast to the proapoptotic effects caused by LC1 overexpression, MAP1B overexpression is not related to cell death related to p53, a tumor-suppressor gene; in fact, MAP1B overexpression reduces p53 transcriptional activity and inhibits doxorubicin-induced apoptosis [21]. The gene discussed is MAP1B; the disease is neoplasm.